Crossmark

The relevance of combined testing of cerebrospinal fluid glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in multiple sclerosis and peripheral neuropathy

Crossref DOI link: https://doi.org/10.1007/s10072-024-07790-4

Published Online: 2024-11-20

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Csecsei, Peter https://orcid.org/0000-0002-4982-2481
Acs, Peter

Gottschal, Marianna

Imre, Piroska

Miklos, Egon

Simon, Diana

Erdo-Bonyar, Szabina

Berki, Timea

Zavori, Laszlo

Varnai, Reka
Funding

Funding for this research was provided by:

University of Pécs
License Information

Text and Data Mining valid from 2024-11-20

Version of Record valid from 2024-11-20
More Information

Article History

Received: 8 July 2024

Accepted: 30 September 2024

First Online: 20 November 2024

Declarations

:

: Study was approved by the Hungarian Medical Research Council (BM/5804-1/2024, BM/5804-3/2024). All procedures were performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki.

: Informed consent was obtained from all subjects involved in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below